Neumora Therapeutics, Inc. (NMRA) — Long-term Investment Intensity
Neumora Therapeutics, Inc. (NMRA) has a Long-term Investment Intensity of 0.1% as of March 2024. Long-term investments of $302.00K represent 0.1% of total assets of $450.21 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See what is Neumora Therapeutics, Inc.'s book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Neumora Therapeutics, Inc. Long-term Investment Intensity (2022–2023)
This chart shows how Neumora Therapeutics, Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2022 to 2023. As of March 2024, the intensity stands at 0.1%, reflecting long-term investments of $302.00K against total assets of $450.21 Million USD. Also explore Neumora Therapeutics, Inc. total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Neumora Therapeutics, Inc. (2022–2023)
The table below presents the year-by-year Long-term Investment Intensity for Neumora Therapeutics, Inc. from 2022 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Neumora Therapeutics, Inc. (NMRA) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 2.0% | $9.85 Million | $496.19 Million | ▼ -3.5 pp |
| 2022 | 5.5% | $23.51 Million | $426.23 Million | — |